123 related articles for article (PubMed ID: 17561720)
21. [Prostate cancer detection by prostate biopsy among Japanese with prostate-specific antigen below 4.0 ng/ml].
Kanno T; Shibasaki N; Tsuji Y; Taki Y; Takeuchi H
Hinyokika Kiyo; 2006 Mar; 52(3):181-4. PubMed ID: 16617870
[TBL] [Abstract][Full Text] [Related]
22. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
23. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml.
Persec Z; Persec J; Sović T; Romic Z; Bosnar Herak M; Hrgovic Z
Onkologie; 2010; 33(3):110-2. PubMed ID: 20215802
[TBL] [Abstract][Full Text] [Related]
24. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
25. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
[TBL] [Abstract][Full Text] [Related]
26. [Small cell carcinoma of the prostate: a case report].
Hashine K; Nakatsuji H; Karashima T; Sumiyoshi Y; Mandai K; Hata A
Hinyokika Kiyo; 1998 Aug; 44(8):607-10. PubMed ID: 9783201
[TBL] [Abstract][Full Text] [Related]
27. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
Rahardjo D; Kamil ST; Pakasi LS
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
[TBL] [Abstract][Full Text] [Related]
28. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
29. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
30. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S
Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078
[TBL] [Abstract][Full Text] [Related]
31. [A Case of Prostate Cancer Diagnosed by the Bone Biopsy of the Right Iliac Metastatic Lesion].
Konishi M; Okamoto S; Yamamoto T; Kanaki T; Oshima J; Kinjo T; Nakata W; Ohashi H; Inoue H
Hinyokika Kiyo; 2023 Jul; 69(7):193-197. PubMed ID: 37558641
[TBL] [Abstract][Full Text] [Related]
32. To treat or not to treat, that is the question: the role of bone-targeted therapy in metastatic prostate cancer.
Higano CS
J Clin Oncol; 2014 Apr; 32(11):1107-11. PubMed ID: 24590651
[TBL] [Abstract][Full Text] [Related]
33. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
34. [Endometrioid adenocarcinoma of the prostate: a case report].
Tsutahara K; Fukuhara S; Mori N; Hara T; Yamaguchi S; Adachi S; Fujisue K
Hinyokika Kiyo; 2004 Sep; 50(9):649-52. PubMed ID: 15518134
[TBL] [Abstract][Full Text] [Related]
35. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
Ishizuka O; Tanabe T; Nakayama T; Kawakami M; Kinebuchi Y; Nishizawa O
Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
[TBL] [Abstract][Full Text] [Related]
36. [Metachronous Pubic Bone Metastases from Synchronous Double Cancer with Prostate and Ascending Colon Cancers : A Case Report].
Ito H; Hishida S; Taniguchi T; Kato D; Takai M; Iinuma K; Muramatsu-Maekawa Y; Kato T; Nakane K; Mizutani K; Tsuchiya T; Takahashi T; Suzui N; Miyazaki T; Koie T
Hinyokika Kiyo; 2020 Aug; 66(8):273-277. PubMed ID: 32882125
[TBL] [Abstract][Full Text] [Related]
37. Does transrectal ultrasound guided eight-core prostate biopsy improve cancer detection rates in patients with prostate-specific antigen levels of 4.1-10 ng/mL?
Yamamoto S; Ito T; Aizawa T; Noda K; Umezu K; Ohtsuru N; Hata K
Int J Urol; 2004 Jun; 11(6):386-91. PubMed ID: 15157207
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of prostate needle biopsies in a population-based screening study: the impact of borderline lesions.
Hoedemaeker RF; Kranse R; Rietbergen JB; Kruger AE; Schröder FH; van der Kwast TH
Cancer; 1999 Jan; 85(1):145-52. PubMed ID: 9921986
[TBL] [Abstract][Full Text] [Related]
39. Detection rate of prostate cancer on biopsy according to serum prostate-specific antigen in Korean men: a multicenter study.
Yang WJ; Lee DH; Chung BH; Cho JS; Choi YD; Kim SJ; Cho IR; Kim HS; Kim CI; Hong SJ;
Urology; 2006 Feb; 67(2):333-6. PubMed ID: 16461083
[TBL] [Abstract][Full Text] [Related]
40. A long follow-up on prostate specific antigen density and prostate biopsy.
Netto Júnior NR; De Lima ML; Lavoura Júnior Nda S; Apuzzo F; De Lucena RG
Arch Esp Urol; 1998 Dec; 51(10):1050-3. PubMed ID: 9951132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
